mirtazapine has been researched along with Adenocarcinoma in 1 studies
Mirtazapine: A piperazinoazepine tetracyclic compound that enhances the release of NOREPINEPHRINE and SEROTONIN through blockage of presynaptic ALPHA-2 ADRENERGIC RECEPTORS. It also blocks both 5-HT2 and 5-HT3 serotonin receptors and is a potent HISTAMINE H1 RECEPTOR antagonist. It is used for the treatment of depression, and may also be useful for the treatment of anxiety disorders.
Adenocarcinoma: A malignant epithelial tumor with a glandular organization.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In this study, anticancer effects of mirtazapine on rats were investigated in an adenocarcinoma model induced by N-methyl-N-nitro-N-nitrosoguanidine (MNNG) and compared with those of cisplatin." | 7.78 | Effect of mirtazapine on MNNG-induced gastric adenocarcinoma in rats. ( Albayrak, A; Bilici, M; Cayir, K; Erdemci, B; Gundogdu, C; Ozogul, B; Suleyman, B; Suleyman, H; Tekin, SB, 2012) |
| "In this study, anticancer effects of mirtazapine on rats were investigated in an adenocarcinoma model induced by N-methyl-N-nitro-N-nitrosoguanidine (MNNG) and compared with those of cisplatin." | 3.78 | Effect of mirtazapine on MNNG-induced gastric adenocarcinoma in rats. ( Albayrak, A; Bilici, M; Cayir, K; Erdemci, B; Gundogdu, C; Ozogul, B; Suleyman, B; Suleyman, H; Tekin, SB, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bilici, M | 1 |
| Cayir, K | 1 |
| Tekin, SB | 1 |
| Gundogdu, C | 1 |
| Albayrak, A | 1 |
| Suleyman, B | 1 |
| Ozogul, B | 1 |
| Erdemci, B | 1 |
| Suleyman, H | 1 |
1 other study available for mirtazapine and Adenocarcinoma
| Article | Year |
|---|---|
Effect of mirtazapine on MNNG-induced gastric adenocarcinoma in rats.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cisplatin; Histamine H1 Antagonists; Immunoenzyme Te | 2012 |